Brazil vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Brazil
- Türkiye
How they compare
Brazil currently reports 35,246 Cases against 132 Cases in Türkiye, a difference of 35,114 Cases.
That makes Brazil's figure about 267.0 times Türkiye's.
Across all 40 years both countries report, Brazil has been ahead every year.
Brazil ranks 1st and Türkiye ranks 3rd of 34 countries.
Brazil has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Brazil | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 1,866 Cases | 3.75 Cases | 1,862 Cases | Brazil |
| 1990s | 19,473 Cases | 28.8 Cases | 19,444 Cases | Brazil |
| 2000s | 38,617 Cases | 45.5 Cases | 38,572 Cases | Brazil |
| 2010s | 41,141 Cases | 101.5 Cases | 41,040 Cases | Brazil |
| 2020s | 32,942 Cases | 63 Cases | 32,879 Cases | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Brazil or Türkiye?
- Brazil, at 35,246 Cases against 132 Cases in Türkiye as of 2021.
- What is the difference in communicable diseases — communicable disease incidence between Brazil and Türkiye?
- 35,114 Cases, with Brazil ahead.
- How many years of comparable data are there for Brazil and Türkiye?
- 40 years are reported by both, from 1982 to 2021.
- How do Brazil and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Brazil ranks 1st and Türkiye ranks 3rd of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.